According to the U.S. Food and Drug Administration (FDA), more than 580,000 bottles of the drug prazosin hydrochloride have been voluntarily recalled nationwide after testing revealed elevated levels of a chemical impurity known as a nitrosamine.

Nitrosamines are a class of compounds that can form during the manufacturing or storage of medications. While they are found in small amounts in everyday foods and water, higher levels over time may increase the risk of cancer, which is why strict limits are enforced in pharmaceuticals.

The affected medication is widely used to treat high blood pressure by relaxing blood vessels and improving blood flow. In some cases, it is also prescribed for conditions such as PTSD-related sleep disturbances.

The FDA has classified this recall as a Class II risk, meaning that while serious health consequences are unlikely, the drug could potentially cause temporary or medically reversible harm if taken.

Pharmaceutical companies involved in the recall, including Teva Pharmaceuticals and Amerisource Health Services, initiated the action after internal testing showed that impurity levels exceeded the agency’s acceptable safety limits.

What Patients Should Do

If you are currently taking this medication, experts strongly advise:

  • Do not stop taking your medication suddenly without consulting your doctor
  • Check your prescription details (dose, manufacturer, lot number)
  • Contact your pharmacist or healthcare provider for guidance or alternatives
  • Return affected medication if instructed

Abruptly stopping blood pressure medication can lead to serious health risks, including spikes in blood pressure or increased risk of heart complications.

Why This Matters

This recall is part of a broader pattern seen in recent years, where certain medications have been pulled due to nitrosamine contamination. These incidents highlight ongoing challenges in drug manufacturing and quality control—and the importance of strict safety monitoring.

While the overall risk to patients is considered low, the discovery of a potential carcinogen is taken seriously by regulators. The recall serves as a reminder to stay informed about medications you take and to respond quickly to safety alerts.

For now, health authorities emphasize that patients should remain calm but proactive—checking their prescriptions, consulting healthcare professionals, and following official guidance to ensure their safety.